By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:



Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.

Company News
National Cancer Institute Awards Kiyatec Nearly $2 Million To Advance Predictive Cancer Diagnostics 9/18/2014 10:14:43 AM
Enumeral Biomedical (ENUM) Awarded Phase II SBIR Contract From The National Cancer Institute To Advance Human Tissue Immuno-Oncology Profiling 9/17/2014 10:46:46 AM
Certain Form Of Baldness Linked To Prostate Cancer, National Cancer Institute Study 9/16/2014 6:30:08 AM
Pharmatech, Inc. Announces Research Collaboration Under Phase II National Cancer Institute/SBIR Grant With Weill Cornell Medical College 9/8/2014 9:44:18 AM
Charles River Laboratories (Massachusetts) Axes Up To 30 Employees Following National Cancer Institute Contract Termination 9/8/2014 5:57:36 AM
Telik, Inc. (TELK) Receives $1.5 Million National Cancer Institute Contract To Develop Novel Antibody-Based PET Imaging Agent For Pancreatic Cancer 8/25/2014 8:59:52 AM
National Cancer Institute Awards $7.3 Million To Kaiser Permanente For Cancer Clinical Trials, Patient Care Research 8/4/2014 6:47:49 AM
Human Metabolome Technologies Joins National Cancer Institute's OSTR Subsidy Program 7/7/2014 10:05:53 AM
PeptiMed Signs Agreement With National Cancer Institute to Assess Safety of HelpTM Drug Delivery Nanoparticle Formulations 6/23/2014 11:43:13 AM
Amgen (AMGN) Joins The National Cancer Institute And Research Partners To Help Accelerate Development Of Personalized Treatment Approaches For Squamous Cell Lung Cancer 6/17/2014 9:59:39 AM